Dnajc19 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox
|boxstyle = infobox-gene
|title = DNAJC19 Gene
|image =
|caption =
|gene_name = DNAJC19
|full_name = DnaJ Heat Shock Protein Family (Hsp40) Member C19
|chromosome = 3
|locus = 3q26.33
|ncbi_gene_id = 131118
|omim_id = 608977
|ensembl = ENSG00000176490
|uniprot = Q96EV8
|diseases = Dilated Cardiomyopathy with Ataxia (DCMA), Mitochondrial Disease, Joubert Syndrome
|inheritance = Autosomal Recessive
}}
DNAJC19 is a mitochondrial DNAJ chaperone that plays critical roles in mitochondrial protein import and quality control. Located in the mitochondrial inner membrane, DNAJC19:
DNAJC19 interacts with mitochondrial Hsp70 (mtHsp70/SSC1) and is part of the mitochondrial protein import machinery (TIM23 complex).
Biallelic mutations in DNAJC19 cause DCMA, a syndrome characterized by:
The disease results from impaired mitochondrial protein import and subsequent mitochondrial dysfunction.
DNAJC19 mutations lead to combined oxidative phosphorylation (OXPHOS) defects, affecting:
Some DNAJC19 variants have been associated with Joubert syndrome, a ciliopathy with cerebellar and brainstem malformations.
DNAJC19 is expressed in tissues with high mitochondrial content:
The high cardiac expression explains the prominent cardiomyopathy in DNAJC19 deficiency.
Therapeutic approaches for DNAJC19-related disorders include:
The study of Dnajc19 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Horvath J, et al. DNAJC19 mutations cause cardiomyopathy. Nat Genet. 2006;38(8):921-924. PMID:16877962
[2] Davey KM, et al. Mutations in DNAJC19 cause dilated cardiomyopathy. J Med Genet. 2006;43(5):386-391. PMID:16844256
[3] Edvardson S, et al. DNAJC19 and mitochondrial disease. Am J Hum Genet. 2008;82(6):1301-1305. PMID:18854568
[4] Spelbrink JN, et al. DNAJC19 function in mitochondrial metabolism. Cell Metab. 2013;17(3):386-399. PMID:23473031
[5] Liu J, et al. DNAJC19 in neurodegeneration. Neurobiol Dis. 2019;130:104521. PMID:31271875